2-[[(2S)-4-methyl-2-[[(2S)-1-[(2S)-3-methyl-2-[(4-methylphenyl)sulfonylamino]butanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]amino]acetic acid allyl ester
Compound with spectra: 1 NMR
![2-[[(2S)-4-methyl-2-[[(2S)-1-[(2S)-3-methyl-2-[(4-methylphenyl)sulfonylamino]butanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]amino]acetic acid allyl ester](/api/compound/ArWFeB54ezp.png?ph=true&h=300&w=458 "2-[[(2S)-4-methyl-2-[[(2S)-1-[(2S)-3-methyl-2-[(4-methylphenyl)sulfonylamino]butanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]amino]acetic acid allyl ester")
| SpectraBase Compound ID | ArWFeB54ezp |
|---|---|
| InChI | InChI=1S/C28H42N4O7S/c1-7-15-39-24(33)17-29-26(34)22(16-18(2)3)30-27(35)23-9-8-14-32(23)28(36)25(19(4)5)31-40(37,38)21-12-10-20(6)11-13-21/h7,10-13,18-19,22-23,25,31H,1,8-9,14-17H2,2-6H3,(H,29,34)(H,30,35)/t22-,23-,25-/m0/s1 |
| InChIKey | RIPPWJVMLNLJGK-LSQMVHIFSA-N |
| Mol Weight | 578.7 g/mol |
| Molecular Formula | C28H42N4O7S |
| Exact Mass | 578.277421 g/mol |
| Enantiomer InChIKey | RIPPWJVMLNLJGK-VDKIKQQVSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
MKN-349A
[2-[(R)-2-OXO-4-PHENYLAZETIDIN-1-YL]-ACETYL]-L-VALYL-L-PROLYL-L-ALANINE-2,2,2-TRICHLOROETHYLESTER
[2-(-2'-Oxo-4'-phenylazetidin-1'-yl)acetyl]-L-valyl-L-prolyl-L-alanine - 2",2",2"-trichloroethyl ester
CYCLO-(L-VAL-D-ILE-L-LEU-L-PRO-D-LEU)
CYCLO[-(D-VAL-L-PRO-L-VAL-D-HYI)4-]-TALLIUM CATION
CYCLO[-(D-VAL-L-PRO-L-VAL-D-HYI)3-]
CYCLO[-(D-VAL-L-PRO-L-VAL-D-HYI)2-] - SODIUM CATION
CYCLO[-(D-VAL-L-PRO-L-VAL-D-HYI)2-]-LITHIUM CATION
CYCLO[-(D-VAL-L-PRO-L-VAL-D-HYI)4-]
| Title | Journal or Book | Year |
|---|---|---|
| Application of the Peptide Claisen Rearrangement toward the Synthesis of Cyclic Peptides | Organic Letters | 1999 |